Template:Candidiasis Treatment - Revision history

Danbot: Convert to AntibioticDose template for SMW integration

2026-03-20T02:24:06Z

Convert to AntibioticDose template for SMW integration

← Revisión anterior		Revisión del 02:24 20 mar 2026
Línea 1:		Línea 1:
	~~<noinclude><languages/></noinclude>~~		====Uncomplicated====
	~~<translate>~~

	====Uncomplicated==== ~~<!--T:1-->~~

	~~<!--T:2-->~~
	''There is little resistance to azole medications; treatment often dictated by patient preference.''		''There is little resistance to azole medications; treatment often dictated by patient preference.''
	*{{AntibioticDose\|disease=Candida vulvovaginitis\|drug=Fluconazole\|dose=150mg PO once\|context=Preferred ~~uncomplicated\|population=Adult~~}} ~~(preferred)~~<ref name=management>Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62:e1.</ref>		*{{AntibioticDose\|disease=Candida vulvovaginitis\|drug=Fluconazole\|dose=150mg PO once\|context=Preferred; a second dose at 72hrs may be given if still symptomatic}}<ref name=management>Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62:e1.</ref>
	**A second dose at 72hrs may be given if patient is still symptomatic
	*Intravaginal therapy		*Intravaginal therapy
	**{{AntibioticDose\|disease=Candida vulvovaginitis\|drug=Clotrimazole\|dose=1% cream vaginally ~~x7d~~ OR 2% vaginally ~~x3d~~\|context=Intravaginal ~~uncomplicated\|population=Adult~~}}		**{{AntibioticDose\|disease=Candida vulvovaginitis\|drug=Clotrimazole\|dose=1% cream applied vaginally for 7 days OR 2% applied vaginally for 3 days\|context=Intravaginal therapy}}
	**{{AntibioticDose\|disease=Candida vulvovaginitis\|drug=Miconazole\|dose=2% cream vaginally ~~x7d~~ OR 4% cream ~~x3d~~\|context=Intravaginal ~~uncomplicated\|population=Adult~~}}		**{{AntibioticDose\|disease=Candida vulvovaginitis\|drug=Miconazole\|dose=2% cream applied vaginally for 7 days OR 4% cream x 3 days\|context=Intravaginal therapy}}
	**Butoconazole 2% applied vaginally x 3 days		**Butoconazole 2% applied vaginally x 3 days
	**Tioconazole 6.5% applied vaginally x 1		**Tioconazole 6.5% applied vaginally x 1
			====Complicated====

	====Complicated==== ~~<!--T:3-->~~

	~~<!--T:4-->~~
	<u>Severe or immunosuppressed</u>		<u>Severe or immunosuppressed</u>
	*{{AntibioticDose\|disease=Candida vulvovaginitis\|drug=Fluconazole\|dose=150mg PO q72h x 3 doses\|context=Severe or immunosuppressed~~\|population=Adult~~}}		*{{AntibioticDose\|disease=Candida vulvovaginitis\|drug=Fluconazole\|dose=150mg PO q72h x 3 doses\|context=Severe or immunosuppressed}}
			<u>Non-albicans species</u>
	~~<!--T:5-->~~
	<u>Non-albicans species</u>
	*For example, C. glabrata, C. krusei and other atypical Candida spp.		*For example, C. glabrata, C. krusei and other atypical Candida spp.
	*Boric acid vaginal suppository intravaginal qday x ≥14 days		*Boric acid vaginal suppository intravaginal qday x ≥14 days
	**Can be fatal if taken orally		**Can be fatal if taken orally
	*If empirically treated and later is found to have non-albicans Candida spp., no change in therapy is needed if patient is improving (otherwise switch to boric acid.		*If empirically treated and later is found to have non-albicans Candida spp., no change in therapy is needed if patient is improving (otherwise switch to boric acid.

	~~<!--T:6-->~~
	<u>Recurrent (≥ 4 infections in a year)</u>		<u>Recurrent (≥ 4 infections in a year)</u>
	*Treat as for uncomplicated (see above)		*Treat as for uncomplicated (see above)
	*Once therapy completed, prescribe long-term treatment		*Once therapy completed, prescribe long-term treatment
	**~~[[Special:MyLanguage/~~Fluconazole\|~~Fluconazole]]~~ 150mg PO qweek x 6 months, OR		**{{AntibioticDose\|disease=Candida vulvovaginitis\|drug=Fluconazole\|dose=150mg PO qweek x 6 months\|context=Recurrent; long-term suppressive therapy}} OR
	**Intravaginal medication, such as clotrimazole 500mg PV qweek or 200mg PV twice a week		**Intravaginal medication, such as clotrimazole 500mg PV qweek or 200mg PV twice a week
			====Pregnant Patients====
			*Intravaginal [[clotrimazole]] or [[miconazole]] are the only recommended treatments
	====Pregnant Patients==== ~~<!--T:7-->~~

	~~<!--T:8-->~~
	*Intravaginal [[~~Special:MyLanguage/clotrimazole\|~~clotrimazole]] or [[~~Special:MyLanguage/miconazole\|~~miconazole]] are the only recommended treatments
	*Duration is 7 days		*Duration is 7 days
	*PO fluconazole associated with congenital malformations and spontaneous abortions<ref>Molgaard-Nielsen D et al. Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. JAMA. 2016;315(1):58-67.</ref>		*PO fluconazole associated with congenital malformations and spontaneous abortions<ref>Molgaard-Nielsen D et al. Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. JAMA. 2016;315(1):58-67.</ref>
	~~</translate>~~

Danbot: Convert to AntibioticDose template with disease=Candida vulvovaginitis for SMW linking

2026-03-20T01:16:40Z

Convert to AntibioticDose template with disease=Candida vulvovaginitis for SMW linking

← Revisión anterior		Revisión del 01:16 20 mar 2026
Línea 6:		Línea 6:
	<!--T:2-->		<!--T:2-->
	''There is little resistance to azole medications; treatment often dictated by patient preference.''		''There is little resistance to azole medications; treatment often dictated by patient preference.''
	*~~[[Special:MyLanguage/~~Fluconazole\|~~Fluconazole]]~~ 150mg PO once (preferred)<ref name=management>Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62:e1.</ref>		*{{AntibioticDose\|disease=Candida vulvovaginitis\|drug=Fluconazole\|dose=150mg PO once\|context=Preferred uncomplicated\|population=Adult}} (preferred)<ref name=management>Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62:e1.</ref>
	**A second dose at 72hrs may be given if patient is still symptomatic		**A second dose at 72hrs may be given if patient is still symptomatic
	*Intravaginal therapy		*Intravaginal therapy
	**~~[[Special:MyLanguage/~~Clotrimazole\|~~Clotrimazole]]~~ 1 % cream ~~applied~~ vaginally ~~for 7 days~~ OR		**{{AntibioticDose\|disease=Candida vulvovaginitis\|drug=Clotrimazole\|dose=1% cream vaginally x7d OR 2% vaginally x3d\|context=Intravaginal uncomplicated\|population=Adult}}
	**[[Special:MyLanguage/Clotrimazole\|Clotrimazole]] 2% ~~applied~~ vaginally ~~for 3 days~~		**{{AntibioticDose\|disease=Candida vulvovaginitis\|drug=Miconazole\|dose=2% cream vaginally x7d OR 4% cream x3d\|context=Intravaginal uncomplicated\|population=Adult}}
	**~~[[Special:MyLanguage/~~Miconazole\|~~Miconazole]]~~ 2% cream ~~applied~~ vaginally ~~for 7 days~~ OR 4% cream ~~x 3 days~~
	**Butoconazole 2% applied vaginally x 3 days		**Butoconazole 2% applied vaginally x 3 days
	**Tioconazole 6.5% applied vaginally x 1		**Tioconazole 6.5% applied vaginally x 1
Línea 20:		Línea 19:
	<!--T:4-->		<!--T:4-->
	<u>Severe or immunosuppressed</u>		<u>Severe or immunosuppressed</u>
	*~~[[Special:MyLanguage/~~Fluconazole\|~~Fluconazole]]~~ 150mg PO q72h x 3 doses		*{{AntibioticDose\|disease=Candida vulvovaginitis\|drug=Fluconazole\|dose=150mg PO q72h x 3 doses\|context=Severe or immunosuppressed\|population=Adult}}

	<!--T:5-->		<!--T:5-->

Ostermayer: Marked this version for translation

2026-01-26T08:31:22Z

Marked this version for translation

← Revisión anterior		Revisión del 08:31 26 ene 2026
Línea 2:		Línea 2:
	<translate>		<translate>

	====Uncomplicated====		====Uncomplicated==== <!--T:1-->

			<!--T:2-->
	''There is little resistance to azole medications; treatment often dictated by patient preference.''		''There is little resistance to azole medications; treatment often dictated by patient preference.''
	*[[Special:MyLanguage/Fluconazole\|Fluconazole]] 150mg PO once (preferred)<ref name=management>Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62:e1.</ref>		*[[Special:MyLanguage/Fluconazole\|Fluconazole]] 150mg PO once (preferred)<ref name=management>Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62:e1.</ref>
Línea 15:		Línea 16:


	====Complicated====		====Complicated==== <!--T:3-->

			<!--T:4-->
	<u>Severe or immunosuppressed</u>		<u>Severe or immunosuppressed</u>
	*[[Special:MyLanguage/Fluconazole\|Fluconazole]] 150mg PO q72h x 3 doses		*[[Special:MyLanguage/Fluconazole\|Fluconazole]] 150mg PO q72h x 3 doses

			<!--T:5-->
	<u>Non-albicans species</u>		<u>Non-albicans species</u>
	*For example, C. glabrata, C. krusei and other atypical Candida spp.		*For example, C. glabrata, C. krusei and other atypical Candida spp.
Línea 26:		Línea 29:
	*If empirically treated and later is found to have non-albicans Candida spp., no change in therapy is needed if patient is improving (otherwise switch to boric acid.		*If empirically treated and later is found to have non-albicans Candida spp., no change in therapy is needed if patient is improving (otherwise switch to boric acid.

			<!--T:6-->
	<u>Recurrent (≥ 4 infections in a year)</u>		<u>Recurrent (≥ 4 infections in a year)</u>
	*Treat as for uncomplicated (see above)		*Treat as for uncomplicated (see above)
Línea 33:		Línea 37:


	====Pregnant Patients====		====Pregnant Patients==== <!--T:7-->

			<!--T:8-->
	*Intravaginal [[Special:MyLanguage/clotrimazole\|clotrimazole]] or [[Special:MyLanguage/miconazole\|miconazole]] are the only recommended treatments		*Intravaginal [[Special:MyLanguage/clotrimazole\|clotrimazole]] or [[Special:MyLanguage/miconazole\|miconazole]] are the only recommended treatments
	*Duration is 7 days		*Duration is 7 days
	*PO fluconazole associated with congenital malformations and spontaneous abortions<ref>Molgaard-Nielsen D et al. Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. JAMA. 2016;315(1):58-67.</ref>		*PO fluconazole associated with congenital malformations and spontaneous abortions<ref>Molgaard-Nielsen D et al. Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. JAMA. 2016;315(1):58-67.</ref>
	</translate>		</translate>

Ostermayer at 08:31, 26 January 2026

2026-01-26T08:31:12Z

← Revisión anterior		Revisión del 08:31 26 ene 2026
Línea 1:		Línea 1:
	<languages/>		<noinclude><languages/></noinclude>
	<translate>		<translate>

Ostermayer: Prepared the page for translation

2026-01-26T08:30:53Z

Prepared the page for translation

← Revisión anterior		Revisión del 08:30 26 ene 2026
Línea 1:		Línea 1:
			<languages/>
			<translate>

	====Uncomplicated====		====Uncomplicated====

	''There is little resistance to azole medications; treatment often dictated by patient preference.''		''There is little resistance to azole medications; treatment often dictated by patient preference.''
	*[[Fluconazole]] 150mg PO once (preferred)<ref name=management>Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62:e1.</ref>		*[[Special:MyLanguage/Fluconazole\|Fluconazole]] 150mg PO once (preferred)<ref name=management>Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62:e1.</ref>
	**A second dose at 72hrs may be given if patient is still symptomatic		**A second dose at 72hrs may be given if patient is still symptomatic
	*Intravaginal therapy		*Intravaginal therapy
	**[[Clotrimazole]] 1 % cream applied vaginally for 7 days OR		**[[Special:MyLanguage/Clotrimazole\|Clotrimazole]] 1 % cream applied vaginally for 7 days OR
	**[[Clotrimazole]] 2% applied vaginally for 3 days		**[[Special:MyLanguage/Clotrimazole\|Clotrimazole]] 2% applied vaginally for 3 days
	**[[Miconazole]] 2% cream applied vaginally for 7 days OR 4% cream x 3 days		**[[Special:MyLanguage/Miconazole\|Miconazole]] 2% cream applied vaginally for 7 days OR 4% cream x 3 days
	**Butoconazole 2% applied vaginally x 3 days		**Butoconazole 2% applied vaginally x 3 days
	**Tioconazole 6.5% applied vaginally x 1		**Tioconazole 6.5% applied vaginally x 1


	====Complicated====		====Complicated====

	<u>Severe or immunosuppressed</u>		<u>Severe or immunosuppressed</u>
	*[[Fluconazole]] 150mg PO q72h x 3 doses		*[[Special:MyLanguage/Fluconazole\|Fluconazole]] 150mg PO q72h x 3 doses

	<u>Non-albicans species</u>		<u>Non-albicans species</u>
Línea 23:		Línea 29:
	*Treat as for uncomplicated (see above)		*Treat as for uncomplicated (see above)
	*Once therapy completed, prescribe long-term treatment		*Once therapy completed, prescribe long-term treatment
	**[[Fluconazole]] 150mg PO qweek x 6 months, OR		**[[Special:MyLanguage/Fluconazole\|Fluconazole]] 150mg PO qweek x 6 months, OR
	**Intravaginal medication, such as clotrimazole 500mg PV qweek or 200mg PV twice a week		**Intravaginal medication, such as clotrimazole 500mg PV qweek or 200mg PV twice a week


	====Pregnant Patients====		====Pregnant Patients====
	*Intravaginal [[clotrimazole]] or [[miconazole]] are the only recommended treatments
			*Intravaginal [[Special:MyLanguage/clotrimazole\|clotrimazole]] or [[Special:MyLanguage/miconazole\|miconazole]] are the only recommended treatments
	*Duration is 7 days		*Duration is 7 days
	*PO fluconazole associated with congenital malformations and spontaneous abortions<ref>Molgaard-Nielsen D et al. Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. JAMA. 2016;315(1):58-67.</ref>		*PO fluconazole associated with congenital malformations and spontaneous abortions<ref>Molgaard-Nielsen D et al. Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. JAMA. 2016;315(1):58-67.</ref>
			</translate>

Rossdonaldson1: /* Uncomplicated */

2024-06-19T22:38:32Z

Uncomplicated

← Revisión anterior		Revisión del 22:38 19 jun 2024
Línea 4:		Línea 4:
	**A second dose at 72hrs may be given if patient is still symptomatic		**A second dose at 72hrs may be given if patient is still symptomatic
	*Intravaginal therapy		*Intravaginal therapy
	**Clotrimazole 1 % cream applied vaginally for 7 days OR		**[[Clotrimazole]] 1 % cream applied vaginally for 7 days OR
	**Clotrimazole 2% applied vaginally for 3 days		**[[Clotrimazole]] 2% applied vaginally for 3 days
	**Miconazole 2% cream applied vaginally for 7 days OR 4% cream x 3 days		**[[Miconazole]] 2% cream applied vaginally for 7 days OR 4% cream x 3 days
	**Butoconazole 2% applied vaginally x 3 days		**Butoconazole 2% applied vaginally x 3 days
	**Tioconazole 6.5% applied vaginally x 1		**Tioconazole 6.5% applied vaginally x 1

Rossdonaldson1 at 22:35, 19 June 2024

2024-06-19T22:35:08Z

← Revisión anterior		Revisión del 22:35 19 jun 2024
Línea 1:		Línea 1:
	====Uncomplicated====		====Uncomplicated====
	''There is little resistance to azole medications; treatment often dictated by patient preference.''		''There is little resistance to azole medications; treatment often dictated by patient preference.''
	*[[Fluconazole]] 150mg PO once (preferred)		*[[Fluconazole]] 150mg PO once (preferred)<ref name=management>Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62:e1.</ref>
	**A second dose at 72hrs may be given if patient is still symptomatic		**A second dose at 72hrs may be given if patient is still symptomatic
	*Intravaginal therapy		*Intravaginal therapy
Línea 27:		Línea 27:

	====Pregnant Patients====		====Pregnant Patients====
	*Intravaginal ~~Clotrimazole~~ or ~~Miconazole~~ are the only recommended treatments		*Intravaginal [[clotrimazole]] or [[miconazole]] are the only recommended treatments
	*Duration is 7 days		*Duration is 7 days
	*PO fluconazole associated with congenital malformations and spontaneous abortions<ref>Molgaard-Nielsen D et al. Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. JAMA. 2016;315(1):58-67.</ref>		*PO fluconazole associated with congenital malformations and spontaneous abortions<ref>Molgaard-Nielsen D et al. Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. JAMA. 2016;315(1):58-67.</ref>

Rossdonaldson1: /* Complicated */

2024-06-19T21:52:02Z

Complicated

← Revisión anterior		Revisión del 21:52 19 jun 2024
Línea 15:		Línea 15:

	<u>Non-albicans species</u>		<u>Non-albicans species</u>
	''For example, C. glabrata, C. krusei and other atypical Candida spp.''		*For example, C. glabrata, C. krusei and other atypical Candida spp.
	*Boric acid vaginal suppository intravaginal qday x ≥14 days		*Boric acid vaginal suppository intravaginal qday x ≥14 days
			**Can be fatal if taken orally
			*If empirically treated and later is found to have non-albicans Candida spp., no change in therapy is needed if patient is improving (otherwise switch to boric acid.

	<u>Recurrent (≥ 4 infections in a year)</u>		<u>Recurrent (≥ 4 infections in a year)</u>

Rossdonaldson1: /* Uncomplicated */

2024-06-19T21:48:06Z

Uncomplicated

← Revisión anterior		Revisión del 21:48 19 jun 2024
Línea 1:		Línea 1:
	====Uncomplicated====		====Uncomplicated====
	''~~Little~~ resistance azole medications; treatment often dictated by patient preference.''		''There is little resistance to azole medications; treatment often dictated by patient preference.''
	*[[Fluconazole]] 150mg PO once (preferred)		*[[Fluconazole]] 150mg PO once (preferred)
	**A second dose at 72hrs may be given if patient is still symptomatic		**A second dose at 72hrs may be given if patient is still symptomatic

Rossdonaldson1 at 21:47, 19 June 2024

2024-06-19T21:47:15Z

← Revisión anterior		Revisión del 21:47 19 jun 2024
Línea 12:		Línea 12:
	====Complicated====		====Complicated====
	<u>Severe or immunosuppressed</u>		<u>Severe or immunosuppressed</u>
	*Fluconazole 150mg PO q72h x 3 doses		*[[Fluconazole]] 150mg PO q72h x 3 doses

	<u>Non-albicans species</u>		<u>Non-albicans species</u>